Skip to main content
. 2009 Jan 20;27(3):390–397. doi: 10.1200/JCO.2008.17.9291

Table 1.

Study Participants Available by Year of Follow-Up and Age at Breast Cancer Diagnosis

Year of Follow-Up Age < 50 Years (n = 199)
Age 50-79 Years (n = 366)
Age 80+ Years (n = 84)
All Participants (N = 649)
No. of Participants % No. of Participants % No. of Participants % No. of Participants %
Eligible at start of follow-up* 196 100 354 100 81 100 631 100
Start of year 2 181 92 338 95 77 95 596 94
Start of year 3 164 84 308 87 65 80 537 85
Start of year 4 138 70 256 72 39 48 433 69
Start of year 5 133 68 238 67 34 42 405 64
End of year 5 119 61 219 62 24 30 362 57
*

Eighteen enrolled participants were found to be ineligible at start of follow-up because there was no unaffected comparison side and lymphedema could not be evaluated, including 17 participants who had simultaneous bilateral mastectomies at the reference date (histologic confirmation of breast cancer diagnosis) and one participant with a pre-existing size difference affecting the entire arm. Among the 631 remaining eligible study participants, an additional six participants recalled a size difference in their hand, lower arm, or upper arm that preceded their breast cancer diagnosis. Five of these six participants had pre-existing size differences in only one part. These pre-existing size differences were not used to calculate incidence of lymphedema, although these six women contributed to estimating incidence rates based on the parts of the arm that were the same at diagnosis.